Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.11.27.21266942: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: After approval by the Mayo Clinic Institutional Review Board (IRB), the MATRx Registry was queried for patients who received MAb and had a diagnosis of pregnancy.18 A total of 86 pregnant patients were identified and their medical records were reviewed and abstracted to collect details such as age, gestational history, gestation at COVID-19 diagnosis, dates of symptom onset and laboratory diagnosis, COVID-19 symptoms, date and type of MAb administration, additional medications, complications, and hospitalization. Sex as a biological variable After approval by the Mayo Clinic Institutional Review Board (IRB), the MATRx Registry was queried for patients who received MAb and had a … SciScore for 10.1101/2021.11.27.21266942: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: After approval by the Mayo Clinic Institutional Review Board (IRB), the MATRx Registry was queried for patients who received MAb and had a diagnosis of pregnancy.18 A total of 86 pregnant patients were identified and their medical records were reviewed and abstracted to collect details such as age, gestational history, gestation at COVID-19 diagnosis, dates of symptom onset and laboratory diagnosis, COVID-19 symptoms, date and type of MAb administration, additional medications, complications, and hospitalization. Sex as a biological variable After approval by the Mayo Clinic Institutional Review Board (IRB), the MATRx Registry was queried for patients who received MAb and had a diagnosis of pregnancy.18 A total of 86 pregnant patients were identified and their medical records were reviewed and abstracted to collect details such as age, gestational history, gestation at COVID-19 diagnosis, dates of symptom onset and laboratory diagnosis, COVID-19 symptoms, date and type of MAb administration, additional medications, complications, and hospitalization. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
